Quercetin and β-sitosterol prevent high fat diet induced dyslipidemia and hepatotoxicity in Swiss albino mice

Indian Journal of Experimental Biology

Volumn 52, Issue 1, 2014, Pages 60-66

  Sikder, Kunal ^a   Das, Nilanjan ^a   Kesh, Swaraj Bandhu ^a   Dey, Sanjit ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

sitosterol; Dyslipidemia; Hepatotoxicity; Quercetin; Steatosis

Indexed keywords

ANTIOXIDANT; CLIONASTEROL; GAMMA-SITOSTEROL; LIPID; QUERCETIN; SITOSTEROL DERIVATIVE; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; DRUG EFFECT; DYSLIPIDEMIA; LIPID DIET; LIPID PEROXIDATION; LIVER; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DIET, HIGH-FAT; DYSLIPIDEMIAS; LIPID PEROXIDATION; LIPIDS; LIVER; MICE; QUERCETIN; SITOSTEROLS; TRIGLYCERIDES;

EID: 84891402932     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Weisberg P S, Leibel R & Tortoriello V D, Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity, Endocrinology, 149 (2008) 3549.
2. Kainuma M, Fujimoto M, Sekiya N, Tsuneyama K, Cheng C, Takano Y, Terasawa K & Shimada Y, Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulinresistant fatty liver disease with characteristic fibrosis, J Gastroenterol, 41 (2006) 971.
3. Brown M S & Goldstein J L, The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, Cell, 89 (1997) 331.
4. McBride P, Triglycerides and risk for coronary artery disease, Curr Atheroscler Rep, 10 (2008) 386.
5. Tajima N, Kurata H, Nakaya N, Mizuno K, Ohashi Y, Kushiro T, Teramoto T, Uchiyama S & Nakamura H, Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patientswith impaired fasting glucose or diabetes: Diabetes subanalysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA) Study, Atherosclerosis, 199 (2008) 455.
6. Preiss D & Sattar N, Prevalence of non-alcoholic fatty liver disease: Population based study, Clin Sci, 115 (2008) 141.
7. Ong J P & Younossi Z M, Epidemiology and natural history of NAFLD and NASH, Clin Liver Dis, 11 (2007)1.
8. Friis L I, Aldenborg F, Jerlstad P, Rundstrom K & Bjornsson E, High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease, Scand J Gastroenterol, 39 (2004) 864.
9. Pogson G W, Kindred L H & Carper B G, Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy, Am J Cardiol, 83 (1999) 1146.
10. Tomaszewski M, Ste{ogonek}pień K M, Tomaszewska J & Czuczwar S J, Statin-induced myopathies, Pharmacol Rep, 63 (2011) 859.
11. Toth B, Nicotinic acid hydrazide carcinogenesis in mice, Oncology, 38 (1981) 106.
12. Song P, Zhang Y & Klaassen C D, Dose-response of five bile acids on serum and liver bile Acid concentrations and hepatotoxicty in mice, Toxicol Sci, 123 (2011) 359.
13. Blane G F, Comparative toxicity and safety profile of fenofibrate and other fibric acid derivatives, Am J Med, 83 (1987) 26.
14. Nhukarume L, Chikwambi Z, Muchuweti M & Chipurura B, Phenolic content and antioxidant capacities of Parinari curatelifolia, Strychnos spinosa and Adansonia digitata, J Food Biochem, 34 (2010) 207.
15. Rice-Evans C A, Miller N J & Pagana G, Structureantioxidant activity relationship of flavonoids and phenolic acids, Free radical Biol Med, 20 (1996) 933.
16. Yi L, Jin X, Chen CY, Fu YJ, Zhang T, Chang H, Zhou Y, Zhu J D, Zhang Q Y Mi M T, Chemical structures of 4-oxoflavonoids in relation to inhibition of oxidized low-density lipoprotein (LDL)-induced vascular endothelial dysfunction, Int J Mol Sci, 12 (2011) 5471.
17. Fernandez M L & Vega-López S, Efficacy and safety of sitosterol in the management of blood cholesterol levels, Cardiovasc Drug Rev, 23 (2005) 57.
18. Folch J, Lees M & Sloane-Stanley G H, A simple method for isolation and purification of total lipids from animal tissues, J Biol Chem, 226 (1957) 497.
19. Lowry O H, Rosebrough N J, Farr A L & Randall R J, Protein measurement with the folin phenol reagent, J Biol Chem, 193 (1951) 265.
20. Marklund S & Marklund G, Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase, Eur J Biochem, 47 (1974) 469.
21. Yumoto I, Ichihashi D, Iwata H, Istokovics A, Ichise N, Matsuyama H, Okuyama H & Kawasaki K, Purification and characterization of a catalase from the facultatively psychrophilic bacterium Vibrio rumoiensis S-1T exhibiting high catalase activity, J Bacteriol, 182 (2000) 1903.
22. Tietze F, Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione, Anal Biochem, 27 (1969) 502.
23. Fakurazi S, Hairuszah I & Nanthini U, Moringa oleifera Lam prevents acetaminophen induced liver injury through restoration of glutathione level, Food Chem Toxicol, 46 (2008) 2611.
24. Ohkawa H, Ohishi N & Yagi K, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, Anal Biochem, 95 (1979) 351.
25. Pessayre D, Mansouri A & Fromenty B, Nonalcoholic steatosis and steatohepatitis.V. Mitochondrial dysfunction in steatohepatitis, Am J Physiol Gastrointest Liver Physiol, 282 (2002) G193.
26. Aragno M, Tomasinelli C E, Vercellinatto I, Catalano M G, Collino M, Fantozzi R, Danni O & Boccuzzi G. SREBP-1c in NAFDL induced by western-type high-fat diet plus fructose in rats, Free Radical Biol Med, 47 (2009) 1067.
27. Demori I, Voci A, Fugassa E & Burlando B, Combined effects of high-fat and ethanol induce oxidative stress in rat liver, Alcohol, 40 (2006) 185.
28. Barbuio R, Milanski M, Bertolo M B, Saad M J & Vellosa L A, Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet, J Endocrinol, 194 (2007) 539.
29. Kesh S B, Sikder K, Manna K, Das D K, Khan A, Das N & Dey S, Promising role of ferulic acid, atorvastatin and their combination in ameliorating high fat diet induced stress in mice, Life science, 92 (2013) 938.
30. Cao G, Sofic E & Prior R L, Antioxidant and prooxidant behaviour of flavonoids: Structure-activity relationships, Free Radic Biol Med, 22 (1997)749.
31. Heijnen C G, Haenen G R, Van Acker F A, Van Der Vijgh W J & Bast A, Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups, Toxicology in Vitro, 15 (2001) 3.
32. Das D K, Chakraborty A, Bhattacharjee S & Dey S, Biosynthesis of stabilised gold nanoparticle using an aglycone flavonoid, Quercetin, J Exp Nanosci, 8 (2013) 649.
33. Das N, Sikder K, Bhattacharjee S, Majumdar SB, Ghosh S, Majumdar S & Dey S, Quercetin alleviates inflammation after short-term treatment in high-fat-fed mice, Food Funct, 4 (2013) 889.
34. Priyadarsini R V & Nagini S, Quercetin suppresses cytochrome P450 mediated ROS generation and NFκB activation to inhibit the development of 7,12-dimethylbenz[a]anthracene (DMBA) induced hamster buccal pouch carcinomas, Free Radic Res, 46 (2012) 41.
35. Angelone T, Pasqua T, Di Majo D, Quintieri A M, Filice E, Amodio N, Tota B, Giammanco M & Cerra M C, Distinct signalling mechanisms are involved in the dissimilar myocardial and coronary effects elicited by quercetin and myricetin, two red wine flavonols, Nutr Metab Cardiovasc Dis, 21 (2011) 362.
36. Mahajan S G & Mehta A A, Suppression of ovalbumininduced Th2-driven airway inflammation by β-sitosterol in a guinea pig model of asthma, Eur J Pharmacol 650 (2011) 458.
37. Das N, Sikder K, Ghosh S, Fromenty B & Dey S, Moringa oleifera Lam. leaf extract prevents early liver injury and restores antioxidant status in mice fed with high-fat diet, Indian J Exp Biol, 50 (2012) 404.
38. Sikder K, Sinha M, Das N, Das D K, Datta S & Dey S, Moringa oleifera leaf extract prevents in vitro oxidative DNA damage, Asian J Pharma Clin Res, 6 (2013) 92.